• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Employer-based insurance coverage increases utilization of planned oocyte cryopreservation.雇主提供的保险覆盖范围增加了计划性卵母细胞冷冻保存的利用率。
J Assist Reprod Genet. 2022 Jun;39(6):1393-1397. doi: 10.1007/s10815-022-02506-z. Epub 2022 May 10.
2
Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation.卵母细胞冷冻保存综述:医学卵母细胞冷冻保存和计划卵母细胞冷冻保存的结果。
Reprod Biol Endocrinol. 2022 Jan 7;20(1):10. doi: 10.1186/s12958-021-00884-0.
3
Evidence-based outcomes after oocyte cryopreservation for donor oocyte in vitro fertilization and planned oocyte cryopreservation: a guideline.经卵母细胞玻璃化冷冻保存用于供体卵母细胞体外受精和计划卵母细胞玻璃化冷冻保存的循证结局:指南。
Fertil Steril. 2021 Jul;116(1):36-47. doi: 10.1016/j.fertnstert.2021.02.024.
4
Utilization of Cryopreserved Oocytes in Patients With Poor Ovarian Response After Planned Oocyte Cryopreservation.计划冷冻卵子后卵巢反应不良患者的冻卵利用。
JAMA Netw Open. 2024 Jan 2;7(1):e2349722. doi: 10.1001/jamanetworkopen.2023.49722.
5
No guarantees: planned oocyte cryopreservation, not quite an insurance policy.无保证:计划的卵母细胞冷冻保存,并非完全是保险政策。
Arch Gynecol Obstet. 2024 Oct;310(4):1889-1894. doi: 10.1007/s00404-024-07654-4. Epub 2024 Aug 3.
6
Oocyte cryopreservation for fertility preservation in women with ovarian endometriosis.卵母细胞冷冻保存用于卵巢子宫内膜异位症女性的生育力保存。
Reprod Biomed Online. 2020 Jun;40(6):827-834. doi: 10.1016/j.rbmo.2020.01.028. Epub 2020 Feb 5.
7
The use of GnRH-agonist trigger for the final maturation of oocytes in normal and low responders undergoing planned oocyte cryopreservation.在计划进行卵母细胞冷冻保存的正常和低反应者中,使用 GnRH 激动剂触发剂进行卵母细胞的最终成熟。
Hum Reprod. 2020 May 1;35(5):1054-1060. doi: 10.1093/humrep/deaa042.
8
The Experience of Fertility Preservation in a Single Tertiary Center in Korea.韩国一家三级医疗中心的生育力保存经验。
Front Endocrinol (Lausanne). 2022 Apr 19;13:845051. doi: 10.3389/fendo.2022.845051. eCollection 2022.
9
Should we perform oocyte accumulation to preserve fertility in women with Turner syndrome? A multicenter study and systematic review of the literature.我们是否应该进行卵母细胞积累以保留特纳综合征女性的生育能力?一项多中心研究及文献系统综述。
Hum Reprod. 2023 Sep 5;38(9):1733-1745. doi: 10.1093/humrep/dead135.
10
A major increase in oocyte cryopreservation cycles in the USA, Australia and New Zealand since 2010 is highlighted by younger women but a need for standardized data collection.自 2010 年以来,美国、澳大利亚和新西兰的卵母细胞冷冻保存周期显著增加,主要是年轻女性推动的,但需要标准化的数据收集。
Hum Reprod. 2021 Feb 18;36(3):624-635. doi: 10.1093/humrep/deaa320.

引用本文的文献

1
Infertility treatment and offspring blood pressure-a systematic review and meta-analysis.不孕症治疗与子代血压——一项系统评价和荟萃分析
Hum Reprod Update. 2025 Jan 1;31(1):2-20. doi: 10.1093/humupd/dmae029.
2
The Status of Fertility Preservation (FP) Insurance Mandates and Their Impact on Utilization and Access to Care.生育力保存(FP)保险授权的现状及其对服务利用和可及性的影响。
J Clin Med. 2024 Feb 14;13(4):1072. doi: 10.3390/jcm13041072.
3
Racial Disparities in Fertility Care: A Narrative Review of Challenges in the Utilization of Fertility Preservation and ART in Minority Populations.生育护理中的种族差异:关于少数族裔人群生育力保存和辅助生殖技术应用挑战的叙述性综述
J Clin Med. 2024 Feb 13;13(4):1060. doi: 10.3390/jcm13041060.
4
Oocyte Cryopreservation for Medical and Planned Indications: A Practical Guide and Overview.用于医疗和计划适应症的卵母细胞冷冻保存:实用指南与概述
J Clin Med. 2023 May 18;12(10):3542. doi: 10.3390/jcm12103542.

本文引用的文献

1
Survey of Fertility Preservation Options Available to Patients With Cancer Around the Globe.全球癌症患者可选择的生育力保存方法调查。
JCO Glob Oncol. 2020 Mar 2;6. doi: 10.1200/JGO.2016.008144. eCollection 2020.
2
Planned oocyte cryopreservation for women seeking to preserve future reproductive potential: an Ethics Committee opinion.拟对有生育潜能保存需求的女性进行卵母细胞冷冻保存:伦理学委员会意见。
Fertil Steril. 2018 Nov;110(6):1022-1028. doi: 10.1016/j.fertnstert.2018.08.027.
3
Medical egg freezing: How cost and lack of insurance cover impact women and their families.医学卵子冷冻:费用及缺乏保险覆盖如何影响女性及其家庭。
Reprod Biomed Soc Online. 2018 Feb 4;5:82-92. doi: 10.1016/j.rbms.2017.12.001. eCollection 2018 Apr.
4
Corporate giants provide fertility benefits: have they got it wrong?企业巨头提供生育福利:他们做错了吗?
Eur J Obstet Gynecol Reprod Biol. 2015 Dec;195:A1-A2. doi: 10.1016/j.ejogrb.2015.10.018. Epub 2015 Oct 30.
5
Does company-sponsored egg freezing promote or confine women's reproductive autonomy?公司赞助的卵子冷冻是促进还是限制了女性的生殖自主权?
J Assist Reprod Genet. 2015 Aug;32(8):1205-9. doi: 10.1007/s10815-015-0500-8. Epub 2015 May 24.
6
Oocyte banking for anticipated gamete exhaustion (AGE) is a preventive intervention, neither social nor nonmedical.为预期配子耗竭 (AGE) 进行卵母细胞冷冻保存是一种预防性干预措施,既不属于社会性措施,也不属于非医学性措施。
Reprod Biomed Online. 2014 May;28(5):548-51. doi: 10.1016/j.rbmo.2014.01.007. Epub 2014 Feb 5.
7
What do reproductive-age women who undergo oocyte cryopreservation think about the process as a means to preserve fertility?接受卵母细胞冷冻保存以保留生育能力的育龄妇女如何看待这一过程?
Fertil Steril. 2013 Nov;100(5):1343-9. doi: 10.1016/j.fertnstert.2013.07.201. Epub 2013 Aug 13.
8
Elective oocyte cryopreservation: who should pay?选择性卵母细胞冷冻保存:应由谁来付费?
Hum Reprod. 2012 Jan;27(1):9-13. doi: 10.1093/humrep/der364. Epub 2011 Nov 13.
9
Efficiency of aseptic open vitrification and hermetical cryostorage of human oocytes.人卵无菌开放式玻璃化冷冻和密封式超低温保存的效率。
Reprod Biomed Online. 2011 Oct;23(4):505-12. doi: 10.1016/j.rbmo.2011.07.003. Epub 2011 Jul 13.
10
Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial.使用冷冻保存的卵母细胞进行赠卵计划:一项前瞻性、随机、对照、临床试验。
Hum Reprod. 2010 Sep;25(9):2239-46. doi: 10.1093/humrep/deq146. Epub 2010 Jun 30.

雇主提供的保险覆盖范围增加了计划性卵母细胞冷冻保存的利用率。

Employer-based insurance coverage increases utilization of planned oocyte cryopreservation.

机构信息

Department of Obstetrics and Gynecology, Lenox Hill Hospital, Northwell Health, New York, NY, USA.

Northwell Health Fertility, Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, USA.

出版信息

J Assist Reprod Genet. 2022 Jun;39(6):1393-1397. doi: 10.1007/s10815-022-02506-z. Epub 2022 May 10.

DOI:10.1007/s10815-022-02506-z
PMID:35536381
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9174362/
Abstract

PURPOSE

To determine the utilization of planned oocyte cryopreservation (OC) in the year immediately prior to, and the year of, insurance coverage commencement for employees at our institution.

METHODS

Patient demographics and cycle outcomes were retrospectively compared between the first OC cycles occurring in 2017 vs. 2018 according to insurance coverage and type, age, and the number of oocytes retrieved and cryopreserved. Continuous demographic variables including age, BMI, day 3 FSH and E2, AMH, gravidity, and parity were compared using student T-tests. Cycle outcomes, including the number of oocytes retrieved and cryopreserved were compared using linear regression models, adjusting for potential confounders including age, BMI, and ovarian reserve parameters.

RESULTS

Between January 2017 and December 2018, 123 patients underwent planned OC at our institution. Patient age ranged from 23 to 44 years and did not significantly differ from 2017 to 2018 (mean 34.9 vs. 35.2). There was a 12% increase in planned OC utilization from 2017 (N = 58) to 2018 (N = 65). Significantly, more patients had any insurance coverage in 2018 vs. 2017 (71.9% vs. 40.4%, p = 0.001), a 78% increase. From 2017 to 2018, the number of patients with hospital-based insurance coverage undergoing planned OC increased by a factor of 8 (5 to 41.5%, p < 0.001), while the number of self-pay patients significantly decreased (p = 0.001). No differences were found regarding cycle outcomes.

CONCLUSION

A greater proportion of women at our institution had insurance coverage for planned OC in 2018 vs. 2017. Employer-based insurance coverage for planned OC was associated with a significant increase in utilization by hospital employees.

摘要

目的

确定在我们机构的员工保险覆盖开始之前和当年,计划卵母细胞冷冻保存(OC)的利用情况。

方法

根据保险覆盖范围和类型、年龄以及取回和冷冻的卵母细胞数量,回顾性比较了 2017 年和 2018 年首次 OC 周期的患者人口统计学和周期结果。使用学生 t 检验比较了连续的人口统计学变量,包括年龄、BMI、第 3 天 FSH 和 E2、AMH、孕次和产次。使用线性回归模型比较了周期结果,包括取回和冷冻的卵母细胞数量,并调整了年龄、BMI 和卵巢储备参数等潜在混杂因素。

结果

在 2017 年 1 月至 2018 年 12 月期间,我们机构的 123 名患者进行了计划 OC。患者年龄从 23 岁到 44 岁不等,与 2017 年到 2018 年没有显著差异(平均 34.9 岁对 35.2 岁)。从 2017 年(N=58)到 2018 年(N=65),计划 OC 的利用率增加了 12%。显著的是,2018 年有更多的患者有任何保险覆盖(71.9%对 40.4%,p=0.001),增加了 78%。从 2017 年到 2018 年,在计划 OC 中接受医院基础保险的患者数量增加了 8 倍(5 例到 41.5%,p<0.001),而自付患者数量显著减少(p=0.001)。在周期结果方面没有发现差异。

结论

与 2017 年相比,我们机构更多的女性在 2018 年有计划 OC 的保险覆盖。雇主为计划 OC 提供的保险覆盖与医院员工利用率的显著增加有关。